Vitamin E-based nanomedicines for anti-cancer drug delivery.
about
Enhanced Bioactivity of α-Tocopheryl Succinate Based Block Copolymer Nanoparticles by Reduced Hydrophobicity.Vitamin E transporters in cancer therapy.Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents deliverypH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E.D-α-tocopheryl polyethylene glycol 1000 succinate functionalized nanographene oxide for cancer therapy.Polymeric drugs: Advances in the development of pharmacologically active polymers.Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.α-Tocopheryl succinate-based amphiphilic block copolymers obtained by RAFT and their nanoparticles for the treatment of cancerFormulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.Review of natural compounds for potential skin cancer treatment.Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.Effects of heterocyclic-based head group modifications on the structure-activity relationship of tocopherol-based lipids for non-viral gene delivery.Amino acid-based cationic lipids with α-tocopherol hydrophobic tail for efficient gene delivery.Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer.P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance.Preparation, Characterization and Evaluation of α-Tocopherol Succinate-Modified Dextran Micelles as Potential Drug CarriersMitochondrially Targeted Nanoparticles Based on α-TOS for the Selective Cancer Treatment.Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.Improved intestinal absorption of paclitaxel by mixed micelles self-assembled from vitamin E succinate-based amphiphilic polymers and their transcellular transport mechanism and intracellular trafficking routes.Synthetically lethal nanoparticles for treatment of endometrial cancer.Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.D-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage.Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents DeliveryImproved physical stability of docosahexaenoic acid and eicosapentaenoic acid encapsulated using nanoliposome containing α-tocopherol
P2860
Q33920277-F8EF657B-2375-4259-9ACE-3E790DB6D0E4Q34451618-9561AB4C-DF50-4065-95D0-5A5D14F50E42Q35182759-538C9C46-222A-40C1-BE57-B6B189B9448AQ35753701-CEFC1AF3-3546-4120-8AC7-0A4C36D63A5CQ35934993-49754652-54DD-4648-A3E9-6BAD86515297Q36250750-66389A44-E357-40BD-A1FA-A4ED3D36EC97Q36274947-A8B64F6B-9176-4696-AB1D-CE596C600E25Q36307604-0DB6F1D3-B4CB-407A-A085-F5E71AE55732Q36680180-1ADC2BC1-EB6A-4782-9884-D29856AF23FCQ36701895-BAD66A84-3B44-4E41-B42A-94295E7FE907Q36731084-A05D1C76-372C-4685-9206-78E512FD0743Q37596129-5D75C789-9149-4AC1-872D-B8EAA7E4BAC3Q38237757-56BFE4AC-E70B-4BBB-B80A-B8C8B58AE82FQ38768934-8CD37456-9B0E-4934-8471-79E21BFF0433Q38937032-9F2CC9FA-3740-43B5-A895-C16852F92491Q40680015-98E63D69-71C3-46B0-8310-EBC52DF15C21Q40940645-DAAB5BAA-1842-471A-B27F-E2B6882ABB47Q41096219-C24C98DA-C14A-47DC-9A53-24E59B11125DQ41273129-306FDAD1-153B-4355-819B-5AEE58B54281Q42228320-62BB2F0A-78E1-42FC-973B-9B23E2571079Q46628896-A8A4B048-A51B-4BDA-A2CF-A2F4B4523878Q46795399-A089D788-F048-49C8-8BC2-19524C2A0AA2Q47219788-1647D2C5-D89D-454B-9878-BB94592EDAB9Q47370432-D1FA6C67-A1C2-4057-A07E-5EA6DB8AD851Q47730228-B39C8BEE-0F38-498D-A346-68C19495A8E0Q47814018-F29B20A4-5442-47C6-84B8-3A88AD17DE7CQ51104841-AF3DF4AF-2522-4E0A-B593-31C4D3B1A1D1Q52783909-EE4B9622-226E-439C-A965-C1ABD18EA992Q55399487-83AFC113-5832-4D1B-8FC3-17B3F9B57660Q57238661-C3501862-2ADC-4163-AA07-AA740FB74089Q58761193-F7EB6DC1-861B-412F-9F16-CEF28AC2C01D
P2860
Vitamin E-based nanomedicines for anti-cancer drug delivery.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@ast
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@en
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@nl
type
label
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@ast
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@en
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@nl
prefLabel
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@ast
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@en
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@nl
P2093
P1476
Vitamin E-based nanomedicines for anti-cancer drug delivery.
@en
P2093
Fabienne Danhier
Nicolas Duhem
Véronique Préat
P356
10.1016/J.JCONREL.2014.03.009
P407
P577
2014-03-12T00:00:00Z